Vividion Therapeutics picks up $50 mln Series A
San Diego-based biotech company Vividion Therapeutics has raised $50 million in Series A funding. ARCH Venture Partners and Versant Ventures led the round with participation from Cardinal Partners.
2 February 2017•1 min read
